Son of an Omicron! What’s Next?
First, there was alpha, then delta, then omicron. Now, the World Health Organization has flagged a new COVID subvariant, the so-called “son of omicron.” A URMC expert tells you what you need to know.
News
Wilmot’s Dialogue Magazine Showcases Diversity and Quest for NCI "Blue Ribbon"
Read about the National Cancer Institute prize that Wilmot seeks in this issue of Dialogue magazine.
EIOH's Teledentistry Success Featured in Major NIH Report
A long-awaited report on oral health in America recently published by the National Institutes of Health includes contributions and highlights research from several experts at Eastman Institute for ...
Trust in Science at Root of Vaccine Acceptance
Results of a global research project indicate that trust in science is the most powerful determinant of whether a person will decide to get a COVID vaccine.
Study Details Lessons Learned from Remote Clinical Studies
A new study by researchers with the University of Rochester Center for Heath + Technology details the experience with three large remote clinical trials in Parkinson's disease and the lessons that ...
Omicron is Spreading: Here’s What Our Scientists Know
The Omicron variant, which emerged in Botswana and South Africa in November of 2021, made its first appearance in Monroe County on December 22 – around the same time it became the dominant variant ...
Misleading Labels: Cannabis e-Cigs Contain Unlisted and Unintended Components
URMC researchers tested 27 cannabis e-cig products and found that none had accurate labeling regarding synthetic THC levels and many contained potentially harmful compounds not listed on the label.
Far from Home for the Holidays, Oral Cancer Survivor Finds Family in Team at Wilmot Cancer Institute
Steve Friedman spent the winter holidays at Wilmot Cancer Institute for a 20-hour head and neck cancer surgery last year. Now, his care team is helping him work toward a better post-treatment quality ...
Honing in on Shared Network of Cancer Genes
Using network modeling, Wilmot Cancer Institute researchers have honed in on a set of gene interactions that are critical to malignancy and likely to be fertile ground for broad cancer therapies.
UR Medicine Creates Alternative Level of Care Units at Strong Memorial, Highland Hospitals
UR Medicine Strong Memorial Hospital this week opened a new, temporary unit for Alternative Level of Care (ALC) patients. These patients no longer need acute, hospital-level care but cannot ...